ES552486A0 - Un procedimiento para la obtencion de compuestos de 1-oxa-1-dertia cefalosporina. - Google Patents

Un procedimiento para la obtencion de compuestos de 1-oxa-1-dertia cefalosporina.

Info

Publication number
ES552486A0
ES552486A0 ES552486A ES552486A ES552486A0 ES 552486 A0 ES552486 A0 ES 552486A0 ES 552486 A ES552486 A ES 552486A ES 552486 A ES552486 A ES 552486A ES 552486 A0 ES552486 A0 ES 552486A0
Authority
ES
Spain
Prior art keywords
sup
group
oxa
dertia
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES552486A
Other languages
English (en)
Other versions
ES8705450A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Merck and Co Inc
Original Assignee
Meiji Seika Kaisha Ltd
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd, Merck and Co Inc filed Critical Meiji Seika Kaisha Ltd
Publication of ES8705450A1 publication Critical patent/ES8705450A1/es
Publication of ES552486A0 publication Critical patent/ES552486A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D505/02—Preparation
    • C07D505/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D505/10—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D505/12—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 substituted in position 7

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
ES552486A 1985-03-01 1986-02-27 Un procedimiento para la obtencion de compuestos de 1-oxa-1-dertia cefalosporina. Expired ES8705450A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/705,799 US4645769A (en) 1985-03-01 1985-03-01 1-oxa-1-dethia-cephalosporin compounds and antibacterial agent comprising the same

Publications (2)

Publication Number Publication Date
ES8705450A1 ES8705450A1 (es) 1987-05-01
ES552486A0 true ES552486A0 (es) 1987-05-01

Family

ID=24835001

Family Applications (2)

Application Number Title Priority Date Filing Date
ES552486A Expired ES8705450A1 (es) 1985-03-01 1986-02-27 Un procedimiento para la obtencion de compuestos de 1-oxa-1-dertia cefalosporina.
ES557155A Expired ES8707726A1 (es) 1985-03-01 1986-10-30 Un procedimiento para la obtencion de compuestos de 1-oxa-1-destia-cefalos-porina

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES557155A Expired ES8707726A1 (es) 1985-03-01 1986-10-30 Un procedimiento para la obtencion de compuestos de 1-oxa-1-destia-cefalos-porina

Country Status (9)

Country Link
US (1) US4645769A (es)
EP (1) EP0193858B1 (es)
JP (1) JPH0633280B2 (es)
KR (1) KR900003500B1 (es)
AT (1) ATE69819T1 (es)
CA (1) CA1268177A (es)
DE (1) DE3682599D1 (es)
DK (1) DK92486A (es)
ES (2) ES8705450A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960002856B1 (ko) * 1987-03-09 1996-02-27 오쓰까 세이야꾸 가부시끼가이샤 2-옥사-이소세펨 화합물, 이를 함유하는 조성물 및 이의 제조방법
DK582788A (da) * 1987-10-22 1989-04-23 Otsuka Pharma Co Ltd 2-oxa-isocephemforbindelser, midler der indeholder dem og fremgangsmaader til fremstilling af dem
US5525599A (en) * 1993-07-21 1996-06-11 Eli Lilly And Company 7-substituted-amino-3-substituted-3-cephem-4-carboxylic acids
JP6377570B2 (ja) * 2014-04-28 2018-08-22 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ ２−置換セフェム化合物を含有する医薬組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226866A (en) * 1972-11-06 1980-10-07 Merck & Co., Inc. Novel antibiotic analogues of cephalosporins
JPS5331690A (en) * 1976-09-01 1978-03-25 Shionogi & Co Ltd Oxadithiacephalosporins
AU514377B2 (en) * 1977-02-15 1981-02-05 Shionogi & Co., Ltd. l-OXADETHIACEPHAM COMPOUNDS
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
DK487979A (da) * 1978-11-17 1980-05-18 Glaxo Group Ltd Fremgangsmaade til fremstilling af cephalosporinantibiotika
FR2474504A1 (fr) * 1979-05-23 1981-07-31 Rhone Poulenc Ind Nouvelles thiovinyl-3 cephalosporines, leur preparation et les medicaments qui les contiennent
HU184771B (en) * 1979-05-23 1984-10-29 Rhone Poulenc Ind Process for producing new 3-thiovinyl-cepheme-carboxylic acid derivatives
DE3137038A1 (de) * 1981-09-17 1983-03-24 Bayer Ag, 5090 Leverkusen Ss-lactam antibiotika, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS5849382A (ja) * 1981-09-18 1983-03-23 Kyowa Hakko Kogyo Co Ltd β−ラクタム化合物
JPS5874680A (ja) * 1981-10-01 1983-05-06 Kyowa Hakko Kogyo Co Ltd β−ラクタム化合物
FR2516515A1 (fr) * 1981-11-16 1983-05-20 Sanofi Sa Nouveaux derives de pyridinium thiomethyl cephalosporines, procede pour leur preparation et compositions pharmaceutiques les contenant
US4534898A (en) * 1982-07-23 1985-08-13 Merck & Co., Inc. 1-Oxa-1-dethia-cephalosporin derivatives

Also Published As

Publication number Publication date
KR860007264A (ko) 1986-10-10
ES557155A0 (es) 1987-08-16
JPH0633280B2 (ja) 1994-05-02
EP0193858A1 (en) 1986-09-10
DK92486A (da) 1986-09-02
DE3682599D1 (de) 1992-01-09
DK92486D0 (da) 1986-02-28
ES8707726A1 (es) 1987-08-16
EP0193858B1 (en) 1991-11-27
KR900003500B1 (ko) 1990-05-21
JPS61251685A (ja) 1986-11-08
ES8705450A1 (es) 1987-05-01
US4645769A (en) 1987-02-24
CA1268177A (en) 1990-04-24
ATE69819T1 (de) 1991-12-15

Similar Documents

Publication Publication Date Title
ES2137386T3 (es) Derivados del 2-oxindol como inhibidores de la tirosina quinasa.
ES8707223A1 (es) Un procedimiento para la preparacion de derivados de benzotiazol y benzotiofen.
ES476343A1 (es) Procedimiento para la obtencion de ciclopentan-1-aminas
ES2073398T3 (es) Nuevos derivados substituidos del acido bencilideno- y cinamilideno-malonico con actividad como inhibidores de la proliferacion celular.
ES552486A0 (es) Un procedimiento para la obtencion de compuestos de 1-oxa-1-dertia cefalosporina.
ES8706690A1 (es) Un procedimiento para la preparacion de nuevos derivados de penem.
ES2016017A6 (es) Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico.
ES2003086A6 (es) Procedimiento de obtencion de tienoquinolicinsulfonamidas
AU576840B2 (en) 1,2,4-thiadiazines
JO1676B1 (en) Extra compounds indinol II
ATE18993T1 (de) Dibenzocycloheptenyliden-verbindungen zur verwendung bei der modulation der immunreaktion.
ES8801648A1 (es) Procedimiento de preparar derivados bisimidazolinoamino, utiles como compuestos antialergicos.
ES8502426A1 (es) Procedimiento para preparar nuevas semicarbazidas

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970203